RE:RE:Still Waiting for 1st Dosed Patientaaacccchhhhh,,,its the middle of November 2021 and Don McCaffrey still cant smooth over the market to even support a RVX liquidation price on our shares and that would include the IP, tax loss and those 10 years of being ahead of all other epigenetic research...amateur at best...memory tells me he noted that no other researcher knows more than RVX when it comes to epigentic knowledge,,,,,believe that if you may!!..the market tells all that his rhetoric is none beliveable,,,,in red neck terms he is full of bovine excrement!!!,,,,,,,I fear the C19 trial will also be a fiasco and follow in the footsteps of the past two decades of trial failures..!!,,most likely they will pick the wrong patient group,,,or have some other entitiy to point the finger at...I say the NY hedge fund will undermine this trial,,,,,lmfao,,,,,pitiful management year after year!!!!,,,